Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.

× No keyword cloud information.

15 in total

1. Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20.

Authors: Yasser Abou Mourad; Ali Taher; Ali Shamseddine
Journal: Hematol J Date: 2003

2. Rituximab: Mechanism of action and resistance.

Authors: David G Maloney; Barbara Smith; Andrea Rose
Journal: Semin Oncol Date: 2002-02 Impact factor: 4.929

Review 3. Tumour lysis syndrome: new therapeutic strategies and classification.

Authors: Mitchell S Cairo; Michael Bishop
Journal: Br J Haematol Date: 2004-10 Impact factor: 6.998

4. Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma.

Authors: R Lerza; M Botta; B Barsotti; E Schenone; M Mencoboni; G Bogliolo; I Pannacciulli; E Arboscello
Journal: Leuk Lymphoma Date: 2002-05

5. Acute spontaneous tumor lysis syndrome.

Authors: A M Jasek; H J Day
Journal: Am J Hematol Date: 1994-10 Impact factor: 10.047

Review 6. Rituximab in B-cell chronic lymphocytic leukemia.

Authors: Thomas S Lin; Margaret S Lucas; John C Byrd
Journal: Semin Oncol Date: 2003-08 Impact factor: 4.929

Review 7. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma.

Authors: S D Scott
Journal: Cancer Pract Date: 1998 May-Jun

8. Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).

Authors: M Jensen; U Winkler; O Manzke; V Diehl; A Engert
Journal: Ann Hematol Date: 1998 Jul-Aug Impact factor: 3.673

Review 9. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.

Authors: Michael B Davidson; Snehal Thakkar; John K Hix; Naveen D Bhandarkar; Alan Wong; Martin J Schreiber
Journal: Am J Med Date: 2004-04-15 Impact factor: 4.965

10. Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin's lymphoma.

Authors: I A Malik; S Abubakar; F Alam; A Khan
Journal: South Med J Date: 1994-03 Impact factor: 0.954

2 in total

1. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.

Authors: Harvey E Johnston; Matthew J Carter; Kerry L Cox; Melanie Dunscombe; Antigoni Manousopoulou; Paul A Townsend; Spiros D Garbis; Mark S Cragg
Journal: Mol Cell Proteomics Date: 2017-01-04 Impact factor: 5.911

Review 2. The safety and side effects of monoclonal antibodies.

Authors: Trevor T Hansel; Harald Kropshofer; Thomas Singer; Jane A Mitchell; Andrew J T George
Journal: Nat Rev Drug Discov Date: 2010-03-22 Impact factor: 84.694

2 in total